The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Delaney Mark E since 2024.
This trader's CIK number is 1955265.
At the time of last reporting, Delaney Mark E was the SVP & Chief Commercial Officer of Quest Diagnostics Inc. (stock ticker symbol DGX).
Also see all insider trading activities at Quest Diagnostics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | DGX | 0 | $0 | 2,151 | $373,013 | 0 | $0 |
| 2024 | DGX | 0 | $0 | 420 | $60,093 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-13 | DGX | Sale | 874 | 175.31 | 153,220 |
| 2025-05-12 | DGX | Sale | 874 | 175.72 | 153,579 |
| 2025-02-05 | DGX | Sale | 403 | 164.30 | 66,214 |
| 2024-07-24 | DGX | Sale | 420 | 143.08 | 60,093 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Delaney Mark E (SVP & Chief Commercial Officer of Quest Diagnostics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.